Incidence and outcomes of osteonecrosis of the jaw from an integrated analysis of three pivotal randomized double-blind, double-dummy phase 3 trials comparing denosumab and zoledronic acid for treatment of bone metastases in advanced cancer patients or myeloma

被引:4
作者
Brown, J. E. [1 ]
Barrios, C. H. [2 ]
Diel, I. J.
Facon, T. [3 ]
Fizazi, K. [4 ]
Ibrahim, T. [5 ]
Saad, F. [6 ]
Senecal, F. [7 ]
Stemmer, S. M. [8 ]
Stopeck, A. [9 ]
Takahashi, S. [10 ]
Van Poznak, C. [11 ]
Zhou, L. [12 ]
Carriere, P. [12 ]
Daniels, A. [12 ]
Dansey, R. [12 ]
机构
[1] Canc Res UK Clin Ctr, Leeds, W Yorkshire, England
[2] PUC RS, Hosp Sao Lucas, Rio Grande Do Sul, Brazil
[3] Hop Claude Huriez, Lille, France
[4] Univ Paris, Inst Gustave Roussy, Villejuif, France
[5] Ist Sci Romagnolo Studio & Cura Tumori, Meldola, Italy
[6] Univ Montreal, Ctr Hosp, Montreal, PQ H3C 3J7, Canada
[7] NW Med Specialties PLLC, Tacoma, WA USA
[8] Rabin Med Ctr, Inst Oncol, Davidoff Ctr, Petah Tiqwa, Israel
[9] Univ Arizona, Arizona Canc Ctr, Tucson, AZ USA
[10] JFCR, Canc Inst Hosp, Koto Ku, Tokyo, Japan
[11] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA
[12] Amgen Inc, Thousand Oaks, CA 91320 USA
关键词
D O I
10.1016/j.bone.2010.10.048
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
引用
收藏
页码:S18 / S19
页数:2
相关论文
empty
未找到相关数据